32 results
Thumbnail

D1.297 - Clinical characteristics of red meat allergy in 19 cases in Jeju

Thumbnail

D1.289 - The buzz that nearly broke a heart: A case of Kounis Syndrome following a Hymenoptera sting

Thumbnail

D1.290 - Identification of a Cheese-Derived κ-Casein Fragment as the Trigger of Anaphylaxis in a Patient with Suspected Pasta Allergy

Thumbnail

D1.291 - Real-world data of nasal adrenaline spray in anaphylaxis: Review of clinical evidence

Thumbnail

D1.292 - Anaphylaxis After Roasted Sunflower Seed Consumption in an Adult: A Case Report

Thumbnail

D1.293 - Hidden allergens revealed by prick-to-prick testing: anaphylaxis triggered by black pepper and cumin

Thumbnail

D1.295 - Patient Perceived Lifestyle Burden with a Nasal Adrenaline Spray vs an Adrenaline Auto- Injector

Thumbnail

D1.296 - Nasal Adrenaline Spray vs Adrenaline Auto-Injectors: When Will People Act?

Thumbnail

D1.298 - Does Previous Anaphylaxis Determine Differences between Patients Undergoing Oral Food Challenges to Cow’s Milk and Hen’s Egg?

Thumbnail

D1.299 - Lychee-Induced Anaphylaxis: Data from the French Allergy-Vigilance Network since 2002

Thumbnail

D1.301 - Non-specific lipid transfer protein allergy: the culprit in disguise

Thumbnail

D1.302 - Allergic Reactions Following Measles-Mumps-Rubella Vaccination in Children with Food Allergy: A Single Center Experience

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.453 - Olfactory outcomes of dupilumab in patients with CRSwNP: A real-world prospective study

Thumbnail

D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD